Use of multifunctional bioactive products derived from the enzymatic hydrolysis of egg clear proteins for the treatment of metabolic syndrome. (Machine-translation by Google Translate, not legally binding)

摘要

The metabolic syndrome is a multifactorial disorder in which several disorders that usually require differentiated pharmacological treatment for each of them converge. The present invention relates to the use of a multifunctional bioactive product derived from the enzymatic hydrolysis of egg white proteins, in the preparation of a pharmaceutical composition and/or a functional food composition, which have utility for the overall treatment of alterations of the egg white. Metabolic syndrome. (Machine-translation by Google Translate, not legally binding)